Skip to main content
Top
Published in: BMC Palliative Care 1/2020

Open Access 01-12-2020 | Lung Cancer | Research article

Implementation of the milestones communication approach for patients with limited prognosis: evaluation of intervention fidelity

Authors: Jasmin Bossert, Michel Wensing, Michael Thomas, Matthias Villalobos, Corinna Jung, Anja Siegle, Laura Hagelskamp, Nicole Deis, Jana Jünger, Katja Krug

Published in: BMC Palliative Care | Issue 1/2020

Login to get access

Abstract

Background

Despite improvements in diagnostics and therapy, the majority of lung tumours are diagnosed at advanced stage IV with a poor prognosis. Due to the nature of an incurable disease, patients need to engage in shared decision making on advance care planning. To implement this in clinical practice, effective communication between patients, caregivers and healthcare professionals is essential. The Heidelberg Milestones Communication Approach (MCA) is delivered by a specifically trained interprofessional tandem and consists of four milestone conversations (MCs) at pivotal times in the disease trajectory. MC 1 (Diagnosis): i.e. prognosis; MC 2 (Stable disease): i.e. prognostic awareness; MC 3 (Progression): i.e. reassessment; MC 4 (Best supportive care): i.e. end of treatment. In between MCs, follow-up calls are carried out to sustain communication. This study aimed to assess to what extent the MCA was implemented as planned and consolidated in specialized oncology practice.

Methods

A prospective observational process evaluation study was conducted, which focused on the implementation fidelity of the MCA. All MCs during two assessment periods were included. We analysed all written records of the conversations, which are part of the routine documentation during MCs and follow-up calls. Adherence to key aspects of the manual was documented on structured checklists at the beginning of the implementation of the MCA and after 6 months. The analysis was descriptive. Differences between the two assessment periods are analysed with chi-square tests.

Results

A total of 133 MCs and 54 follow-up-calls (t1) and of 172 MCs and 92 follow-up calls (t2) were analysed. MC 2 were the most frequently completed conversations (n = 51 and n = 47). Advance care planning was discussed in 26 and 13% of MC 2 in the respective assessment periods; in 31 and 47% of MC 2, prognostic awareness was recorded. The most frequently documented topic in the follow-up calls was the physical condition in patients (82 and 83%).

Conclusion

The implementation of a trajectory-specific communication concept was largely successful. Additional studies are needed to understand how fidelity could be further improved.

Trial registration

DRKS00013469 / Date of registration: 22.12.2017.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cheng T-YD, Cramb SM, Baade PD, Youlden DR, Nwogu C, Reid ME. The international epidemiology of lung cancer: latest trends, disparities, and tumor characteristics. J Thorac Oncol. 2016;11(10):1653–71.CrossRef Cheng T-YD, Cramb SM, Baade PD, Youlden DR, Nwogu C, Reid ME. The international epidemiology of lung cancer: latest trends, disparities, and tumor characteristics. J Thorac Oncol. 2016;11(10):1653–71.CrossRef
2.
go back to reference Grønberg BH, Sundstrøm S, Kaasa S, Bremnes RM, Fløtten Ø, Amundsen T, Hjelde HH, von Plessen C, Jordhøy M. Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy. Eur J Cancer. 2010;46(12):2225–34.CrossRef Grønberg BH, Sundstrøm S, Kaasa S, Bremnes RM, Fløtten Ø, Amundsen T, Hjelde HH, von Plessen C, Jordhøy M. Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy. Eur J Cancer. 2010;46(12):2225–34.CrossRef
3.
go back to reference Eberle A, Jansen L, Castro F, Krilaviciute A, Luttmann S, Emrich K, Holleczek B, Nennecke A, Katalinic A, Brenner H. Lung cancer survival in Germany: a population-based analysis of 132,612 lung cancer patients. Lung Cancer. 2015;90(3):528–33.CrossRef Eberle A, Jansen L, Castro F, Krilaviciute A, Luttmann S, Emrich K, Holleczek B, Nennecke A, Katalinic A, Brenner H. Lung cancer survival in Germany: a population-based analysis of 132,612 lung cancer patients. Lung Cancer. 2015;90(3):528–33.CrossRef
4.
go back to reference Grose D, Morrison DS, Devereux G, Jones R, Sharma D, Selby C, Docherty K, McIntosh D, Nicolson M, McMillan DC. The impact of comorbidity upon determinants of outcome in patients with lung cancer. Lung Cancer. 2015;87(2):186–92.CrossRef Grose D, Morrison DS, Devereux G, Jones R, Sharma D, Selby C, Docherty K, McIntosh D, Nicolson M, McMillan DC. The impact of comorbidity upon determinants of outcome in patients with lung cancer. Lung Cancer. 2015;87(2):186–92.CrossRef
5.
go back to reference Yanwei L, Dongying L, Zhuchen Y, Ling L, Yu Z, Zhanyu P. A double-edged sword: should stage IV non-small cell lung cancer patients be informed of their cancer diagnosis? Eur J Cancer Care. 2017;26(6):e12665.CrossRef Yanwei L, Dongying L, Zhuchen Y, Ling L, Yu Z, Zhanyu P. A double-edged sword: should stage IV non-small cell lung cancer patients be informed of their cancer diagnosis? Eur J Cancer Care. 2017;26(6):e12665.CrossRef
6.
go back to reference Epstein AS, Prigerson HG, O’Reilly EM, Maciejewski PK. Discussions of life expectancy and changes in illness understanding in patients with advanced cancer. J Clin Oncol. 2016;34(20):2398.CrossRef Epstein AS, Prigerson HG, O’Reilly EM, Maciejewski PK. Discussions of life expectancy and changes in illness understanding in patients with advanced cancer. J Clin Oncol. 2016;34(20):2398.CrossRef
7.
go back to reference Siegle A, Villalobos M, Bossert J, Krug K, Hagelskamp L, Krisam J, Handtke V, Deis N, Jünger J, Wensing M. The Heidelberg milestones communication approach (MCA) for patients with prognosis< 12 months: protocol for a mixed-methods study including a randomized controlled trial. Trials. 2018;19(1):438.CrossRef Siegle A, Villalobos M, Bossert J, Krug K, Hagelskamp L, Krisam J, Handtke V, Deis N, Jünger J, Wensing M. The Heidelberg milestones communication approach (MCA) for patients with prognosis< 12 months: protocol for a mixed-methods study including a randomized controlled trial. Trials. 2018;19(1):438.CrossRef
8.
go back to reference Barth J, Lannen P. Efficacy of communication skills training courses in oncology: a systematic review and meta-analysis. Ann Oncol. 2010;22(5):1030–40.CrossRef Barth J, Lannen P. Efficacy of communication skills training courses in oncology: a systematic review and meta-analysis. Ann Oncol. 2010;22(5):1030–40.CrossRef
9.
go back to reference Moore PM, Rivera S, Bravo-Soto GA, Olivares C, Lawrie TA. Communication skills training for healthcare professionals working with people who have cancer. Cochrane Database Syst Rev. 2018;7. Moore PM, Rivera S, Bravo-Soto GA, Olivares C, Lawrie TA. Communication skills training for healthcare professionals working with people who have cancer. Cochrane Database Syst Rev. 2018;7.
10.
go back to reference Baile WF, Aaron J. Patient-physician communication in oncology: past, present, and future. Curr Opin Oncol. 2005;17(4):331–5.CrossRef Baile WF, Aaron J. Patient-physician communication in oncology: past, present, and future. Curr Opin Oncol. 2005;17(4):331–5.CrossRef
11.
go back to reference Villalobos M, Coulibaly K, Krug K, Kamradt M, Wensing M, Siegle A, Kuon J, Eschbach C, Tessmer G, Winkler E. A longitudinal communication approach in advanced lung cancer: a qualitative study of patients’, relatives’ and staff's perspectives. Eur J Cancer Care. 2018;27(2):e12794.CrossRef Villalobos M, Coulibaly K, Krug K, Kamradt M, Wensing M, Siegle A, Kuon J, Eschbach C, Tessmer G, Winkler E. A longitudinal communication approach in advanced lung cancer: a qualitative study of patients’, relatives’ and staff's perspectives. Eur J Cancer Care. 2018;27(2):e12794.CrossRef
12.
go back to reference Slaughter SE, Hill JN, Snelgrove-Clarke E. What is the extent and quality of documentation and reporting of fidelity to implementation strategies: a scoping review. Implement Sci. 2015;10(1):129.CrossRef Slaughter SE, Hill JN, Snelgrove-Clarke E. What is the extent and quality of documentation and reporting of fidelity to implementation strategies: a scoping review. Implement Sci. 2015;10(1):129.CrossRef
13.
go back to reference Willeboordse F, Schellevis F, Meulendijk M, Hugtenburg J, Elders P. Implementation fidelity of a clinical medication review intervention: process evaluation. Int J Clin Pharm. 2018;40(3):550–65.CrossRef Willeboordse F, Schellevis F, Meulendijk M, Hugtenburg J, Elders P. Implementation fidelity of a clinical medication review intervention: process evaluation. Int J Clin Pharm. 2018;40(3):550–65.CrossRef
14.
go back to reference Atkins L, Francis J, Islam R, O’Connor D, Patey A, Ivers N, Foy R, Duncan EM, Colquhoun H, Grimshaw JM. A guide to using the theoretical domains framework of behaviour change to investigate implementation problems. Implement Sci. 2017;12(1):77.CrossRef Atkins L, Francis J, Islam R, O’Connor D, Patey A, Ivers N, Foy R, Duncan EM, Colquhoun H, Grimshaw JM. A guide to using the theoretical domains framework of behaviour change to investigate implementation problems. Implement Sci. 2017;12(1):77.CrossRef
15.
go back to reference Richards DA. The complex interventions framework. In: Complex interventions in health. Routledge; 2015. p. 27–41. Richards DA. The complex interventions framework. In: Complex interventions in health. Routledge; 2015. p. 27–41.
16.
go back to reference Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet. 2003;362(9391):1225–30.CrossRef Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet. 2003;362(9391):1225–30.CrossRef
17.
go back to reference Baumann A, Cabassa LJ, Wiltsey Stirman S. Adaptation in dissemination and implementation science. In: Dissemination and implementation research in health: translating science to practice, vol. 2; 2017. p. 286–300. Baumann A, Cabassa LJ, Wiltsey Stirman S. Adaptation in dissemination and implementation science. In: Dissemination and implementation research in health: translating science to practice, vol. 2; 2017. p. 286–300.
18.
go back to reference Baile WF, Buckman R, Lenzi R, Glober G, Beale EA, Kudelka AP. SPIKES—a six-step protocol for delivering bad news: application to the patient with cancer. Oncologist. 2000;5(4):302–11.CrossRef Baile WF, Buckman R, Lenzi R, Glober G, Beale EA, Kudelka AP. SPIKES—a six-step protocol for delivering bad news: application to the patient with cancer. Oncologist. 2000;5(4):302–11.CrossRef
19.
go back to reference Fischer GS, Tulsky JA, Arnold RM. Communicating a poor prognosis. Topics in palliative care. 2000;4:75–94. Fischer GS, Tulsky JA, Arnold RM. Communicating a poor prognosis. Topics in palliative care. 2000;4:75–94.
20.
go back to reference Holland J, Watson M, Dunn J. The IPOS new international standard of quality Cancer care: integrating the psychosocial domain into routine care. Psychooncology. 2011;20(7):677–80.CrossRef Holland J, Watson M, Dunn J. The IPOS new international standard of quality Cancer care: integrating the psychosocial domain into routine care. Psychooncology. 2011;20(7):677–80.CrossRef
21.
go back to reference Cutbush S, Gibbs D, Krieger K, Clinton-Sherrod M, Miller S. Implementers' perspectives on Fidelity of implementation. Health Promot Pract. 2017;18(2):275–82.CrossRef Cutbush S, Gibbs D, Krieger K, Clinton-Sherrod M, Miller S. Implementers' perspectives on Fidelity of implementation. Health Promot Pract. 2017;18(2):275–82.CrossRef
22.
go back to reference Rietjens JA, Sudore RL, Connolly M, van Delden JJ, Drickamer MA, Droger M, van der Heide A, Heyland DK, Houttekier D, Janssen DJ. Definition and recommendations for advance care planning: an international consensus supported by the European Association for Palliative Care. Lancet Oncol. 2017;18(9):e543–51.CrossRef Rietjens JA, Sudore RL, Connolly M, van Delden JJ, Drickamer MA, Droger M, van der Heide A, Heyland DK, Houttekier D, Janssen DJ. Definition and recommendations for advance care planning: an international consensus supported by the European Association for Palliative Care. Lancet Oncol. 2017;18(9):e543–51.CrossRef
23.
go back to reference Robbins-Welty GA, Mueser L, Mitchell C, Pope N, Arnold R, Park S, White D, Smith KJ, Reynolds C, Rosenzweig M. Interventionist training and intervention fidelity monitoring and maintenance for CONNECT, a nurse-led primary palliative care in oncology trial. Contemp Clin Trials commun. 2018;10:57–61.CrossRef Robbins-Welty GA, Mueser L, Mitchell C, Pope N, Arnold R, Park S, White D, Smith KJ, Reynolds C, Rosenzweig M. Interventionist training and intervention fidelity monitoring and maintenance for CONNECT, a nurse-led primary palliative care in oncology trial. Contemp Clin Trials commun. 2018;10:57–61.CrossRef
24.
go back to reference Richards Z, Kostadinov I, Jones M, Richard L, Cargo M. Assessing implementation fidelity and adaptation in a community-based childhood obesity prevention intervention. Health Educ Res. 2014;29(6):918–32.CrossRef Richards Z, Kostadinov I, Jones M, Richard L, Cargo M. Assessing implementation fidelity and adaptation in a community-based childhood obesity prevention intervention. Health Educ Res. 2014;29(6):918–32.CrossRef
25.
go back to reference Tang ST, Liu T-W, Liu LN, Chiu C-F, Hsieh R-K, Tsai C-M. Physician–patient end-of-life care discussions: correlates and associations with end-of-life care preferences of cancer patients—a cross-sectional survey study. Palliat Med. 2014;28(10):1222–30.CrossRef Tang ST, Liu T-W, Liu LN, Chiu C-F, Hsieh R-K, Tsai C-M. Physician–patient end-of-life care discussions: correlates and associations with end-of-life care preferences of cancer patients—a cross-sectional survey study. Palliat Med. 2014;28(10):1222–30.CrossRef
26.
go back to reference Applebaum AJ, Kolva EA, Kulikowski JR, Jacobs JD, DeRosa A, Lichtenthal WG, Olden ME, Rosenfeld B, Breitbart W. Conceptualizing prognostic awareness in advanced cancer: a systematic review. J Health Psychol. 2014;19(9):1103–19.CrossRef Applebaum AJ, Kolva EA, Kulikowski JR, Jacobs JD, DeRosa A, Lichtenthal WG, Olden ME, Rosenfeld B, Breitbart W. Conceptualizing prognostic awareness in advanced cancer: a systematic review. J Health Psychol. 2014;19(9):1103–19.CrossRef
27.
go back to reference Janssens A, Teugels L, Kohl S, Michielsen T, Van Meerbeeck J. Integrating early palliative care (EPC) in the management of lung cancer: the role of the thoracic oncologist. Lung Cancer. 2015;90(2):135–8.CrossRef Janssens A, Teugels L, Kohl S, Michielsen T, Van Meerbeeck J. Integrating early palliative care (EPC) in the management of lung cancer: the role of the thoracic oncologist. Lung Cancer. 2015;90(2):135–8.CrossRef
28.
go back to reference Zwakman M, Jabbarian L, van Delden J, van der Heide A, Korfage I, Pollock K, Rietjens J, Seymour J, Kars M. Advance care planning: a systematic review about experiences of patients with a life-threatening or life-limiting illness. Palliat Med. 2018;32(8):1305–21.CrossRef Zwakman M, Jabbarian L, van Delden J, van der Heide A, Korfage I, Pollock K, Rietjens J, Seymour J, Kars M. Advance care planning: a systematic review about experiences of patients with a life-threatening or life-limiting illness. Palliat Med. 2018;32(8):1305–21.CrossRef
29.
go back to reference Shanafelt T, Dyrbye L. Oncologist burnout: causes, consequences, and responses. J Clin Oncol. 2012;30(11):1235–41.CrossRef Shanafelt T, Dyrbye L. Oncologist burnout: causes, consequences, and responses. J Clin Oncol. 2012;30(11):1235–41.CrossRef
30.
go back to reference Peppercorn JM, Smith TJ, Helft PR, DeBono DJ, Berry SR, Wollins DS, Hayes DM, Von Roenn JH, Schnipper LE. American society of clinical oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol. 2011;29(6):755–60.CrossRef Peppercorn JM, Smith TJ, Helft PR, DeBono DJ, Berry SR, Wollins DS, Hayes DM, Von Roenn JH, Schnipper LE. American society of clinical oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol. 2011;29(6):755–60.CrossRef
31.
go back to reference Rogers EM. The innovation-decision process. Diffusion of innovations, vol. 5; 2003. p. 168–218. Rogers EM. The innovation-decision process. Diffusion of innovations, vol. 5; 2003. p. 168–218.
32.
go back to reference Santacroce SJ, Maccarelli LM, Grey M. Intervention fidelity. Nurs Res. 2004;53(1):63–6.CrossRef Santacroce SJ, Maccarelli LM, Grey M. Intervention fidelity. Nurs Res. 2004;53(1):63–6.CrossRef
33.
go back to reference Desrochers F, Donivan E, Mehta A, Laizner AM. A psychosocial oncology program: perceptions of the telephone-triage assessment. Support Care Cancer. 2016;24(7):2937–44.PubMed Desrochers F, Donivan E, Mehta A, Laizner AM. A psychosocial oncology program: perceptions of the telephone-triage assessment. Support Care Cancer. 2016;24(7):2937–44.PubMed
34.
go back to reference Hasson H. Systematic evaluation of implementation fidelity of complex interventions in health and social care. Implement Sci. 2010;5(1):67.CrossRef Hasson H. Systematic evaluation of implementation fidelity of complex interventions in health and social care. Implement Sci. 2010;5(1):67.CrossRef
Metadata
Title
Implementation of the milestones communication approach for patients with limited prognosis: evaluation of intervention fidelity
Authors
Jasmin Bossert
Michel Wensing
Michael Thomas
Matthias Villalobos
Corinna Jung
Anja Siegle
Laura Hagelskamp
Nicole Deis
Jana Jünger
Katja Krug
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Palliative Care / Issue 1/2020
Electronic ISSN: 1472-684X
DOI
https://doi.org/10.1186/s12904-020-0527-1

Other articles of this Issue 1/2020

BMC Palliative Care 1/2020 Go to the issue